ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1510

Joint CD8+ Tissue Resident Memory Cell Activation Produces Local Inflammatory Arthritis

Sahar Lotfi-Emran and David Masopust, University of Minnesota, Minneapolis, MN

Meeting: ACR Convergence 2021

Keywords: CD8+ T cell, inflammatory arthritis, resident memory T cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (1507–1515)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Following infection, resident memory CD8+ T cells (TRM) populate tissues as long lived sentinel cells. Their aberrant activation can trigger relapsing inflammation in autoimmune diseases with a strong site- and tissue-specific component such as inflammatory arthritis. Virus specific CD8+ T cells are a recognized component of synovial fluid and synovial biopsies from individuals with autoimmune arthritis. Here, we demonstrate vesicular stomatitis virus encoding ovalbumin (VSV-OVA) specific CD8+ T cells in the mouse knee following resolution of acute infection. With antigen exposure, joint TRM proliferate and recruit additional immune cells preferentially to the site of activation.

Methods: OT1 lymphocytes express a transgenic TCR which recognizes the SIINFEKL peptide of ovalbumin. CD45.1+OT-1 cells are transferred intravascular (i.v.) to CD45.2+ C57BL/6 recipient mice. The next day, recipient mice received 106 PFU VSV-OVA i.v. Thirty days after infection, mice receive intra-articular (i.a.) SIINFEKL, PBS alone, or no injection. Knees are fixed, decalcified with EDTA, and frozen. Slides were stained with DAPI, anti-CD45.1, anti-collagen II, streptavidin-PE or streptavidin-C594, anti-B220, anti-Ly6G, and anti-CD4.

Results: Stimulation with SIINFEKL peptide induces proliferation of TRM in target joint but not in opposite joint as demonstrated by both increased OT-1 numbers and their proportion to all cells as identified by DAPI staining (Figure 1A). Increased OT-1 numbers are accompanied by increased B cells, Neutrophils, and CD4 cells within the joint space. (Figure 1B-D).

Conclusion: Following acute infection with VSV-OVA, CD45.1+ donor OT-1 cells populate both joint synovium at a timepoint well past resolution of acute infection. As with TRM at other sites, they proliferate in response to antigenic stimulation and recruit additional inflammatory cells to the joint space.

Slide1.jpeg”Figure 1. Intra-articular OT_1, B220, Ly6G, and CD4 enumeration. Connecting lines indicate paired knees from same indiivudal mouse. *,p < 0.01, ANOVA followed by Tukey’s multiple comparison.


Disclosures: S. Lotfi-Emran, None; D. Masopust, None.

To cite this abstract in AMA style:

Lotfi-Emran S, Masopust D. Joint CD8+ Tissue Resident Memory Cell Activation Produces Local Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/joint-cd8-tissue-resident-memory-cell-activation-produces-local-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-cd8-tissue-resident-memory-cell-activation-produces-local-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology